Recent News
Insights about prostate cancer resistance could lead to treatment strategies
In the journal Molecular Cell, researchers led by UNC Lineberger's G. Greg Wang, PhD, and H. Shelton Earp, MD, describe the role of a protein variant called androgen receptor variant 7 (AR-V7), which is an alternative form of the androgen receptor that plays a key role in prostate cancer development and treatment.
Metastatic breast cancer patients report high level of financial impact
A study led by UNC Lineberger's Stephanie Wheeler, PhD, investigated the extent and severity of negative financial effects of cancer among women with breast cancer that has spread in the body. The preliminary results were presented at the American Society of Clinical Oncology’s Quality Care Symposium, held Sept. 28-29 in Phoenix.
Study focused on improving radiation treatment for cancers in pet dogs
UNC Lineberger's Paul A. Dayton, PhD, and his colleagues have been awarded a five-year, $3.2 million grant from the National Cancer Institute to investigate how to improve radiation treatment for pet dogs undergoing treatment for sarcoma.
Susan G. Komen awards UNC Lineberger $1.1M for breast cancer research
Included in the new investments by Susan G. Komen was $400,000 for UNC Lineberger’s Lisa Carey, MD, the physician-in-chief of the N.C. Cancer Hospital, Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, chief of the UNC School of Medicine Division of Hematology/Oncology, and a member of the Komen Scientific Advisory Board, for a study of HER2-positive breast cancer.